3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Leukemia, Myeloid, Acute
11
Myelodysplastic Syndromes
9
Lymphoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Leukemia
6
Hematologic Neoplasms
6
Neuroblastoma
4
Neoplasms
4
Melanoma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Leukemia, B-Cell
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Lymphoid
3
Hodgkin Disease
3
Hematologic Diseases
3
Sarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Preleukemia
2
Precancerous Conditions
2
Osteosarcoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms by Histologic Type
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid
2
Interventions
durvalumab
13
Bevacizumab
11
Nivolumab
10
tremelimumab
7
pembrolizumab
6
lenvatinib
6
fludarabine
6
Cyclophosphamide
6
atezolizumab
4
Radiosurgery
4
Cisplatin
4
toripalimab
3
relatlimab
3
Magnetic Resonance Imaging
3
Ipilimumab
3
Gemcitabine
3
X-Rays
2
Standard of Care
2
Sorafenib
2
Riluzole
2
Radiotherapy
2
Photons
2
Patient Navigation
2
Lidocaine
2
Hepatectomy
2
Dexamethasone
2
Biopsy
2
trastuzumab deruxtecan
1
tocilizumab
1
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Mesna
×
1 year
×
Clear all
No trials found.